ID   PLD2_HUMAN              Reviewed;         933 AA.
AC   O14939; I3L2C9; O43540; O43579; O43580; Q6PGR0; Q96BY3;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   12-APR-2017, entry version 165.
DE   RecName: Full=Phospholipase D2;
DE            Short=PLD 2;
DE            Short=hPLD2;
DE            EC=3.1.4.4;
DE   AltName: Full=Choline phosphatase 2;
DE   AltName: Full=PLD1C;
DE   AltName: Full=Phosphatidylcholine-hydrolyzing phospholipase D2;
GN   Name=PLD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PLD2A; PLD2B AND PLD2C),
RP   CHARACTERIZATION, AND VARIANT CYS-172.
RC   TISSUE=Brain;
RX   PubMed=9761774;
RA   Steed P.M., Clark K.L., Boyar W.C., Lasala D.J.;
RT   "Characterization of human PLD2 and the analysis of PLD isoform splice
RT   variants.";
RL   FASEB J. 12:1309-1317(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PLD2A), CHARACTERIZATION, AND
RP   VARIANT ILE-577.
RC   TISSUE=B-cell;
RX   PubMed=9582313; DOI=10.1074/jbc.273.21.12846;
RA   Lopez I., Arnold R.S., Lambeth J.D.;
RT   "Cloning and initial characterization of a human phospholipase D2
RT   (hPLD2). ADP-ribosylation factor regulates hPLD2.";
RL   J. Biol. Chem. 273:12846-12852(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PLD2A AND PLD2B), AND VARIANTS
RP   GLY-632 AND SER-821.
RA   Saqib K.M., Clark J.M., Byrd P.J., Armstrong S.J., Wakelam M.J.O.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PLD2A), AND VARIANTS
RP   CYS-172; ILE-577 AND GLY-632.
RC   TISSUE=Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH PIP5K1B.
RX   PubMed=11032811; DOI=10.1093/emboj/19.20.5440;
RA   Divecha N., Roefs M., Halstead J.R., D'Andrea S., Fernandez-Borga M.,
RA   Oomen L., Saqib K.M., Wakelam M.J.O., D'Santos C.;
RT   "Interaction of the type Ialpha PIPkinase with phospholipase D: a role
RT   for the local generation of phosphatidylinositol 4, 5-bisphosphate in
RT   the regulation of PLD2 activity.";
RL   EMBO J. 19:5440-5449(2000).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-807.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: May have a role in signal-induced cytoskeletal
CC       regulation and/or endocytosis. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: A phosphatidylcholine + H(2)O = choline + a
CC       phosphatidate.
CC   -!- ENZYME REGULATION: Stimulated by phosphatidylinositol 4,5-
CC       bisphosphate and activated by the ADP-ribosylation factor-1 (ARF-
CC       1).
CC   -!- SUBUNIT: Interacts with EGFR (By similarity). Interacts with
CC       PIP5K1B. {ECO:0000250, ECO:0000269|PubMed:11032811}.
CC   -!- INTERACTION:
CC       P23528:CFL1; NbExp=2; IntAct=EBI-1053996, EBI-352733;
CC       P62993:GRB2; NbExp=4; IntAct=EBI-1053996, EBI-401755;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=PLD2A;
CC         IsoId=O14939-1; Sequence=Displayed;
CC       Name=PLD2C;
CC         IsoId=O14939-3; Sequence=VSP_005027;
CC       Name=PLD2B;
CC         IsoId=O14939-4; Sequence=VSP_054769;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Phosphorylated by FGR. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the phospholipase D family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Phospholipase D entry;
CC       URL="https://en.wikipedia.org/wiki/Phospholipase_D";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF033850; AAD04197.1; -; mRNA.
DR   EMBL; AF035483; AAC24498.1; -; mRNA.
DR   EMBL; AF038440; AAB96655.1; -; mRNA.
DR   EMBL; AF038441; AAB96656.1; -; mRNA.
DR   EMBL; AC233723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90405.1; -; Genomic_DNA.
DR   EMBL; BC015033; AAH15033.1; -; mRNA.
DR   EMBL; BC056871; AAH56871.1; -; mRNA.
DR   CCDS; CCDS11057.1; -. [O14939-1]
DR   CCDS; CCDS58507.1; -. [O14939-4]
DR   RefSeq; NP_001230037.1; NM_001243108.1. [O14939-4]
DR   RefSeq; NP_002654.3; NM_002663.4. [O14939-1]
DR   UniGene; Hs.104519; -.
DR   ProteinModelPortal; O14939; -.
DR   BioGrid; 111354; 44.
DR   DIP; DIP-38903N; -.
DR   IntAct; O14939; 4.
DR   MINT; MINT-141629; -.
DR   STRING; 9606.ENSP00000263088; -.
DR   BindingDB; O14939; -.
DR   ChEMBL; CHEMBL2734; -.
DR   DrugBank; DB00122; Choline.
DR   GuidetoPHARMACOLOGY; 1434; -.
DR   SwissLipids; SLP:000000108; -.
DR   iPTMnet; O14939; -.
DR   PhosphoSitePlus; O14939; -.
DR   BioMuta; PLD2; -.
DR   EPD; O14939; -.
DR   MaxQB; O14939; -.
DR   PaxDb; O14939; -.
DR   PeptideAtlas; O14939; -.
DR   PRIDE; O14939; -.
DR   DNASU; 5338; -.
DR   Ensembl; ENST00000263088; ENSP00000263088; ENSG00000129219. [O14939-1]
DR   Ensembl; ENST00000572940; ENSP00000459571; ENSG00000129219. [O14939-4]
DR   GeneID; 5338; -.
DR   KEGG; hsa:5338; -.
DR   UCSC; uc002fzc.4; human. [O14939-1]
DR   CTD; 5338; -.
DR   DisGeNET; 5338; -.
DR   GeneCards; PLD2; -.
DR   H-InvDB; HIX0013451; -.
DR   HGNC; HGNC:9068; PLD2.
DR   HPA; HPA013397; -.
DR   MIM; 602384; gene.
DR   neXtProt; NX_O14939; -.
DR   OpenTargets; ENSG00000129219; -.
DR   PharmGKB; PA33397; -.
DR   eggNOG; KOG1329; Eukaryota.
DR   eggNOG; COG1502; LUCA.
DR   GeneTree; ENSGT00390000008356; -.
DR   HOGENOM; HOG000246972; -.
DR   HOVERGEN; HBG006650; -.
DR   InParanoid; O14939; -.
DR   KO; K01115; -.
DR   OMA; HHETLNF; -.
DR   OrthoDB; EOG091G017Y; -.
DR   PhylomeDB; O14939; -.
DR   TreeFam; TF300589; -.
DR   BRENDA; 3.1.4.4; 2681.
DR   BRENDA; 4.2.1.1; 2681.
DR   Reactome; R-HSA-1483148; Synthesis of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
DR   SignaLink; O14939; -.
DR   SIGNOR; O14939; -.
DR   ChiTaRS; PLD2; human.
DR   GeneWiki; PLD2; -.
DR   GenomeRNAi; 5338; -.
DR   PRO; PR:O14939; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000129219; -.
DR   CleanEx; HS_PLD2; -.
DR   ExpressionAtlas; O14939; baseline and differential.
DR   Genevisible; O14939; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0070290; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; IEA:UniProtKB-EC.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0004630; F:phospholipase D activity; TAS:Reactome.
DR   GO; GO:0048870; P:cell motility; IBA:GO_Central.
DR   GO; GO:0007010; P:cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0048017; P:inositol lipid-mediated signaling; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc.
DR   GO; GO:0036465; P:synaptic vesicle recycling; TAS:ParkinsonsUK-UCL.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR025202; PLD-like_dom.
DR   InterPro; IPR001736; PLipase_D/transphosphatidylase.
DR   InterPro; IPR016555; PLipase_D1/D2.
DR   InterPro; IPR015679; PLipase_D_fam.
DR   PANTHER; PTHR18896; PTHR18896; 1.
DR   Pfam; PF00614; PLDc; 1.
DR   Pfam; PF13091; PLDc_2; 1.
DR   Pfam; PF00787; PX; 1.
DR   PIRSF; PIRSF009376; Phospholipase_D_euk; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00155; PLDc; 2.
DR   SMART; SM00312; PX; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS50035; PLD; 2.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat.
FT   CHAIN         1    933       Phospholipase D2.
FT                                /FTId=PRO_0000218805.
FT   DOMAIN       65    195       PX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00147}.
FT   DOMAIN      203    311       PH.
FT   DOMAIN      437    464       PLD phosphodiesterase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   DOMAIN      751    778       PLD phosphodiesterase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   REGION      441    788       Catalytic.
FT   VAR_SEQ     337    933       Missing (in isoform PLD2C).
FT                                {ECO:0000303|PubMed:9761774}.
FT                                /FTId=VSP_005027.
FT   VAR_SEQ     810    821       RFALSLRKHCFG -> S (in isoform PLD2B).
FT                                {ECO:0000303|PubMed:9761774,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_054769.
FT   VARIANT     172    172       R -> C (in dbSNP:rs2286672).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9761774}.
FT                                /FTId=VAR_051704.
FT   VARIANT     577    577       T -> I (in dbSNP:rs1052748).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9582313}.
FT                                /FTId=VAR_051705.
FT   VARIANT     632    632       E -> G (in dbSNP:rs17854914).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_061750.
FT   VARIANT     804    804       A -> T (in dbSNP:rs11545163).
FT                                /FTId=VAR_051706.
FT   VARIANT     807    807       Q -> E (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036503.
FT   VARIANT     821    821       G -> R (in dbSNP:rs3764897).
FT                                /FTId=VAR_051707.
FT   VARIANT     821    821       G -> S (in dbSNP:rs3764897).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_059774.
FT   CONFLICT     16     16       D -> G (in Ref. 3; AAB96656).
FT                                {ECO:0000305}.
FT   CONFLICT    165    165       Y -> C (in Ref. 3; AAB96656).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       R -> C (in Ref. 3; AAB96656).
FT                                {ECO:0000305}.
FT   CONFLICT    268    268       Q -> R (in Ref. 3; AAB96655).
FT                                {ECO:0000305}.
FT   CONFLICT    325    325       S -> R (in Ref. 3; AAB96656).
FT                                {ECO:0000305}.
FT   CONFLICT    445    445       L -> P (in Ref. 3; AAB96656).
FT                                {ECO:0000305}.
FT   CONFLICT    510    510       D -> G (in Ref. 3; AAB96656).
FT                                {ECO:0000305}.
FT   CONFLICT    566    566       T -> I (in Ref. 3; AAB96655).
FT                                {ECO:0000305}.
FT   CONFLICT    784    784       D -> G (in Ref. 3; AAB96656).
FT                                {ECO:0000305}.
FT   CONFLICT    801    802       MN -> ID (in Ref. 2; AAC24498).
FT                                {ECO:0000305}.
SQ   SEQUENCE   933 AA;  105987 MW;  F25F6B73B45F57ED CRC64;
     MTATPESLFP TGDELDSSQL QMESDEVDTL KEGEDPADRM HPFLAIYELQ SLKVHPLVFA
     PGVPVTAQVV GTERYTSGSK VGTCTLYSVR LTHGDFSWTT KKKYRHFQEL HRDLLRHKVL
     MSLLPLARFA VAYSPARDAG NREMPSLPRA GPEGSTRHAA SKQKYLENYL NRLLTMSFYR
     NYHAMTEFLE VSQLSFIPDL GRKGLEGMIR KRSGGHRVPG LTCCGRDQVC YRWSKRWLVV
     KDSFLLYMCL ETGAISFVQL FDPGFEVQVG KRSTEARHGV RIDTSHRSLI LKCSSYRQAR
     WWAQEITELA QGPGRDFLQL HRHDSYAPPR PGTLARWFVN GAGYFAAVAD AILRAQEEIF
     ITDWWLSPEV YLKRPAHSDD WRLDIMLKRK AEEGVRVSIL LFKEVELALG INSGYSKRAL
     MLLHPNIKVM RHPDQVTLWA HHEKLLVVDQ VVAFLGGLDL AYGRWDDLHY RLTDLGDSSE
     SAASQPPTPR PDSPATPDLS HNQFFWLGKD YSNLITKDWV QLDRPFEDFI DRETTPRMPW
     RDVGVVVHGL PARDLARHFI QRWNFTKTTK AKYKTPTYPY LLPKSTSTAN QLPFTLPGGQ
     CTTVQVLRSV DRWSAGTLEN SILNAYLHTI RESQHFLYIE NQFFISCSDG RTVLNKVGDE
     IVDRILKAHK QGWCYRVYVL LPLLPGFEGD ISTGGGNSIQ AILHFTYRTL CRGEYSILHR
     LKAAMGTAWR DYISICGLRT HGELGGHPVS ELIYIHSKVL IADDRTVIIG SANINDRSLL
     GKRDSELAVL IEDTETEPSL MNGAEYQAGR FALSLRKHCF GVILGANTRP DLDLRDPICD
     DFFQLWQDMA ESNANIYEQI FRCLPSNATR SLRTLREYVA VEPLATVSPP LARSELTQVQ
     GHLVHFPLKF LEDESLLPPL GSKEGMIPLE VWT
//
